Berk–Tabatznik syndrome
| Berk–Tabatznik syndrome | |
|---|---|
| Synonyms | Berk syndrome, Tabatznik syndrome |
| Pronounce | N/A |
| Specialty | Cardiology |
| Symptoms | Arrhythmia, palpitations, syncope |
| Complications | N/A |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history of the condition |
| Diagnosis | Electrocardiogram (ECG), genetic testing |
| Differential diagnosis | Long QT syndrome, Brugada syndrome |
| Prevention | N/A |
| Treatment | Beta blockers, antiarrhythmic drugs, implantable cardioverter-defibrillator (ICD) |
| Medication | N/A |
| Prognosis | Variable, depends on severity and treatment |
| Frequency | Rare |
| Deaths | N/A |
Berk–Tabatznik syndrome is a rare genetic disorder characterized by short stature, intellectual disability, and distinctive facial features. The syndrome was first described by Dr. Berk and Dr. Tabatznik in 1984.
Symptoms and Signs[edit]
The most common symptoms of Berk–Tabatznik syndrome include:
- Short stature
- Intellectual disability
- Distinctive facial features such as a broad forehead, deep-set eyes, and a small chin
- Other physical abnormalities may also be present
Causes[edit]
Berk–Tabatznik syndrome is a genetic disorder, which means it is caused by changes (mutations) in one or more genes. However, the specific genes involved in this syndrome are not yet known.
Diagnosis[edit]
Diagnosis of Berk–Tabatznik syndrome is based on the presence of characteristic clinical features. Genetic testing may also be used to confirm the diagnosis.
Treatment[edit]
There is currently no cure for Berk–Tabatznik syndrome. Treatment is supportive and based on the symptoms present in each individual.
See Also[edit]
References[edit]